These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1478257)

  • 1. Modification of muscarinic acetylcholine receptors in the rat brain following chronic immobilization stress: an autoradiographic study.
    González AM; Pazos A
    Eur J Pharmacol; 1992 Nov; 223(1):25-31. PubMed ID: 1478257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity changes in muscarinic acetylcholine receptors in the rat brain following acute immobilization stress: an autoradiographic study.
    González AM; Pazos A
    Eur J Pharmacol; 1992 Apr; 214(2-3):261-8. PubMed ID: 1516642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
    Cortés R; Palacios JM
    Brain Res; 1986 Jan; 362(2):227-38. PubMed ID: 3942874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.
    Lee JH; el-Fakahany EE
    Eur J Pharmacol; 1985 Apr; 110(2):263-6. PubMed ID: 3987816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic cholinergic receptors: autoradiographic localization of high and low affinity agonist binding sites.
    Wamsley JK; Zarbin MA; Birdsall NJ; Kuhar MJ
    Brain Res; 1980 Oct; 200(1):1-12. PubMed ID: 7417800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased binding of the muscarinic antagonist [3H]N-methylscopolamine in mouse brain following acute treatment with an organophosphate.
    Cioffi CL; el-Fakahany EE
    Eur J Pharmacol; 1986 Dec; 132(2-3):147-54. PubMed ID: 3816972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
    Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
    Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of piracetam administration on 3H-N-methylscopolamine binding in cerebral cortex of young and old rats.
    Viana GS; Marinho MM; Sousa FC
    Life Sci; 1992; 50(13):971-7. PubMed ID: 1548981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
    Rinner I; Porta S; Schauenstein K
    Endocrinol Exp; 1990 Mar; 24(1-2):125-32. PubMed ID: 2361455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue.
    Lepor H; Kuhar MJ
    J Urol; 1984 Aug; 132(2):397-402. PubMed ID: 6204069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WAGxDA rat: an animal model of cholinergic supersensitivity.
    Orpen G; Steiner M
    Biol Psychiatry; 1995 Jun; 37(12):874-83. PubMed ID: 7548462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of muscarinic acetylcholine receptors in cultured guinea pig pancreatic acini.
    Hootman SR; Brown ME; Williams JA; Logsdon CD
    Am J Physiol; 1986 Jul; 251(1 Pt 1):G75-83. PubMed ID: 2425639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.